BIO

BIO-RAD LABORATORIES INC

Healthcare | Mid Cap

$2.86

EPS Forecast

$585.6

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

$2.86

Revenue Forecast:

$585.6

EPS Surprise Forecast:

$0.093

Revenue Surprise Forecast:

$4

Post-release price volatility - Medium

Post-release Overnight Move:

±6.0%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

60%

Probability of beating revenue consensus:

59%

Probability of beating both EPS & revs consensus:

43%

Probability of missing both EPS & revs consensus:

23%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-1

Beta (β)

Forward Looking Beta (β):

0.61

Earnings volatility

EPS standard deviation:

$1.21

Revenue standard deviation:

$46

As % of share price:

0.46% HIGH

As % of market cap:

0.64% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$4.50

Revenue 95th %ile:

$647

EPS 75th %ile:

$3.30

Revenue 75th %ile:

$602

EPS 25th %ile:

$2.53

Revenue 25th %ile:

$571

EPS 5th %ile:

$1.59

Revenue 5th %ile:

$535

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

44% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

32% HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$25

Bid-ask per Share:

$0.65